AbSci
  • About Us
  • Careers
  • News
  • Contact
  • Facebook
  • Twitter
  • Linkedin
Select Page

AbSci Announces Strategic Investment by Merck Global Health Innovation Fund

Feb 22, 2021 | Uncategorized

VANCOUVER, Wash., – February 22, 2021 – AbSci, a pioneering synthetic biology company that unifies biologic drug discovery and development processes, today announced a strategic equity investment by Merck Global Health Innovation Fund (Merck GHI) and potential...

AbSci Enters Biologics Development Collaboration with Xyphos Biosciences, an Astellas Company

Feb 3, 2021 | Uncategorized

-Second molecule addressed under the collaboration agreement, first to exploit AbSci discovery technologies-  VANCOUVER, Wash., February 3, 2021 /PRNewswire/ — AbSci, a pioneering synthetic biology company enabling drug discovery and biomanufacturing of...

Recent Posts

  • AbSci Announces Strategic Investment by Merck Global Health Innovation Fund
  • AbSci Enters Biologics Development Collaboration with Xyphos Biosciences, an Astellas Company
  • AbSci Announces Acquisition of Deep Learning Company Denovium
  • AbSci to Present at the 39th Annual J.P. Morgan Healthcare Conference
  • AbSci Announces Recent Additions to Board of Directors

Archives

  • February 2021
  • January 2021
  • November 2020
  • October 2020
  • September 2020
  • January 2020
  • July 2019
  • March 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • July 2018
  • May 2018
  • February 2018
  • January 2018
  • December 2017
  • October 2017
  • August 2017
  • April 2017
  • January 2017
  • October 2016
  • August 2016
  • May 2016
  • April 2016
  • October 2015
SEE ARCHIVE

Categories

  • Announcement
  • Article
  • Award
  • Fundraising
  • News
  • Press
  • Uncategorized

Designed by Elegant Themes | Powered by WordPress